Responsible use of antibiotics on sheep farms: application at farm level by Lovatt, Fiona et al.
Responsible Use of Antibiotics on Sheep Farms  1 
Application at Farm Level 2 
 3 
Fiona Lovatt, Davinia Hinde and Jennifer Duncan 4 
Introduction 5 
 6 
There is global concern over rising levels of antibiotic resistance amongst commensal 7 
and pathogenic bacteria in human and animal populations. It is now considered that 8 
unless urgent action is taken by the medical and veterinary professions, we will enter 9 
a post- antibiotic era where bacterial diseases which were readily treatable with 10 
antibiotics will once again kill. Consequently, the use of antibiotics in both the 11 
human and animal health industries has come under intense scrutiny.  Long held 12 
ideas and accepted behavioural norms have rightly been challenged.  Progress in the 13 
agricultural industries has developed apace with the development of the Responsible 14 
Use of Medicine in Agriculture (RUMA) Target Task Force in December 2016 and the 15 
Department for Environment, Food and Rural Affairs (DEFRA) call for the 16 
implementation of sector-specific targets on antibiotic use.   17 
Examination of antibiotic use in the sheep sector led by The RUMA Target Report [1], 18 
the Sheep Veterinary Society (SVS) [2] and supported by recent research [3] have 19 
identified that the areas of concern for the veterinary profession with regards to 20 
prescribing practices for sheep surround three specific disease management issues:- 21 
i. Whole flock prophylactic antibiotic treatments for control of 22 
infectious lameness. 23 
ii. Whole flock prophylactic antibiotic treatments for prevention of 24 
enzootic abortion. 25 
iii. Whole flock prophylactic treatment of lambs against neonatal 26 
bacterial infections.  27 
Responsible use of antibiotics in livestock is an ethical issue as we must at all times 28 
balance and justify our decisions in light of our primary consideration as a profession 29 
to uphold animal welfare. Current thinking on responsible antibiotic use in livestock 30 
is that whilst treatment of individual sick animals with appropriate antibiotic therapy 31 
is always justifiable, metaphylactic treatment of groups of animals can be justifiable, 32 
prophylactic treatment of whole flocks or lamb crops is rarely justifiable (BOX1&2). 33 
There are many more tools available to us to manage these bacterial diseases aside 34 
from antibiotics, including; biosecurity, vaccination, hygiene measures, nutrition and 35 
other management actions. The responsibility lies with us as veterinary professionals 36 
to work closely with our clients to encourage their uptake and reduce dependence 37 
on prophylactic antibiotic strategies.  38 
 39 
BOX 1: British Veterinary Association (BVA) Position on Use of Antibiotics in Food 40 
Producing Animals  41 
 42 
1. BVA recognises antimicrobial resistance (AMR) as an issue of critical importance to 43 
society as a whole and is committed to providing leadership on this issue. Our overall 44 
aspiration is to reduce the use of antibiotics in animals under our care alongside 45 
improving the health and welfare of those animals, particularly through disease 46 
prevention strategies.  47 
2. It is not possible to raise animals in sterile conditions; infections in animals are a 48 
reality and antibiotics will remain vital to treat bacterial infections in individual 49 
animals and in groups of animals managed within the same environment. 50 
Metaphylaxis will continue to be necessary in the face of disease outbreaks in groups 51 
of animals in order to minimise disease spread. Oral antibiotic treatments are 52 
effective and efficient methods of medicine delivery in some populations of 53 
terrestrial and aquatic animals.  54 
3. BVA does not support the habitual use of prophylactic antibiotics. Animal 55 
husbandry systems reliant on such use must be interrogated and action plans 56 
developed to limit repeat disease occurrence and investigate alternative strategies 57 
for disease control, which may in turn impact upon the cost of food.  58 
4. BVA opposes the introduction of arbitrary, non-evidence based target setting; 59 
such targets, to reduce antibiotic use, risk restricting vets’ ability to treat animal 60 
diseases, which could have serious public health and animal welfare implications. 61 
However, we support the use of evidence-based targets to reduce antibiotic usage in 62 
animal agriculture, which are likely to form part of the solution to address AMR 63 
globally. 64 
BOX 2: Sheep Veterinary Society (SVS) Policy on Responsible Use of Antimicrobials 65 
in Sheep (2017) 66 
 67 
1. It is essential that veterinary surgeons comply with the current veterinary 68 
medicines regulations regarding the prescribing of antibiotics and regulated by the 69 
Veterinary Medicines Directorate (VMD). 70 
2. In addition veterinary surgeons should ensure they are prescribing in accordance 71 
with BVA guidance on responsible use of antibiotics. 72 
3. Veterinary surgeons should engage with continuing professional development 73 
(CPD) on antimicrobial resistance and responsible antibiotic use. 74 
4. All antibiotics should be prescribed responsibly, following current professional 75 
guidelines. However, in addition, the European Medicines Agency and the VMD 76 
consider special attention be paid to prescribing antibiotics according to the 77 
categorisation below:- 78 
 79 
European Medicines Agency (EMA) Antimicrobial Expert Group (AMEG) 80 
Classification of WHO Critically Important Antimicrobial (CIAs) based on degree 81 
of risk to humans due to antimicrobial resistance development following use in 82 
animals 83 
Category  Risk to Public  
Health 
Antimicrobial Included  Advice on Use  
A. Authorised CIA 
1 Low/limited 
risk to 
public health 
Narrow spectrum Penicillins, 
Macrolides, Tetracycline 
General principles of 
responsible use to be 
applied 
2 Higher risk to 
public health 
Fluoroquinolones, systemic 
3rd and 4th generation 
Cephalosporins, 
Restricted to use 
where there are no 
alternatives or 
response to 
(Aminogylcosides, broad 
spectrum Pencillins) Colistin 
alternatives 
expected to be poor  
 84 
 85 
5. Veterinary surgeons should work to reduce the total amount of antibiotics used 86 
on farms by encouraging uptake by farmers of alternate methods of disease 87 
control wherever possible. These include biosecurity, vaccination, improved farm 88 
hygiene and other management actions. Currently, areas where veterinary 89 
surgeons may be able to make the most impact to reduce the use of antibiotics on 90 
sheep farms are:- 91 
iv. Blanket treatment of lambs against neonatal bacterial infections 92 
v. Whole flock antibiotic treatments for lameness  93 
vi. Whole flock antibiotic treatments for enzootic abortion.  94 
 95 
6. All sheep farms should have a health plan written in conjunction with their 96 
veterinary surgeon and reviewed at least annually. A review of preventative health 97 
strategies and antimicrobial use should be included in the health plan. 98 
 99 
To support and encourage the profession in this endeavour, the Sheep Veterinary 100 
Society, alongside other planned activities, has produced “Good Practice Guidelines” 101 
[4] which detail their view on responsible antibiotic use for these diseases and it is 102 
these Guidelines that form the basis of this article. 103 
Quite simply, the primary recommendations are that, in order to replace, refine and 104 
reduce antibiotics in these target areas, vets and sheep farmers should work to plan 105 
ahead, prevent disease and protect their flocks. 106 
 107 
Lameness 108 
Lameness in sheep is a common and serious welfare problem for many sheep flocks. 109 
In the analysis of data from 24 flocks served by one practice, two-thirds of the total 110 
antibiotic prescribed was primarily for sheep lameness (fig 1) [3].  In the UK lameness 111 
is largely due to bacterial infectious causes e.g. scald, footrot and contagious ovine 112 
digital dermatitis (CODD) (Figure 2 a,b,c)).   113 
It should be noted that it is entirely appropriate to promptly treat all sheep that are 114 
clinically affected with one of these bacterial infections with an antibiotic injection[5, 115 
6]. Indeed, it may also be entirely appropriate to isolate and treat whole groups of 116 
clinically affected sheep in a flock.  However whole flock treatments with antibiotics, 117 
and antibiotic foot bathing are not considered appropriate strategies (see below). 118 
Therefore the important challenge for lameness in sheep flocks is to reduce the 119 
number of new clinical cases of lameness that need antibiotic treatment.   120 
 121 
 122 
BOX 3: “The Five Point Plan” [7] 123 
THE FIVE POINT PLAN  
1. Cull badly or repeatedly affected animals  
2. Quarantine incoming animals 
3. Treat clinical cases promptly 
4. Avoid propagation of infection on farm 
5. Vaccinate against foot rot biannually 
 124 
  125 
 126 
Plan 127 
The “Five Point Plan” (fig 3) [7] is the current sheep industry accepted standard for 128 
lameness control. It usefully summarises the tools which are available for lameness 129 
control on sheep flocks. Some or all of these can be applied on an individual farm 130 
basis following detailed veterinary investigation and formation of a farm specific 131 
plan. This should include:- 132 
• Diagnosis of the causes of lameness in a flock.  133 
• Assessment of farm specific risk factors. For example, seasonal trends, 134 
hygiene, housing, handling areas and field management. 135 
• Design and application of farm specific disease control measures.  136 
Reassuringly, research evidence shows that a reduction in new cases of lameness is 137 
fully achievable if the current tools available for lameness control are fully 138 
considered and applied by vets and farmers when tackling lameness in their flocks 139 
[7-9].  For further information, colleagues are referred to two recent articles for 140 
reviews of the current evidence base for management of footrot [5] and CODD [6] in 141 
sheep.  142 
 143 
Prevent 144 
The primary source of Dichelobacter and treponemes are from infected sheep 145 
though they will survive on pasture to some degree.  Reducing the bacterial 146 
challenge on farm and thereby preventing sheep coming into contact with agents 147 
causing lameness can be through attention to the following areas:-  148 
• Optimise hygiene of buildings, and handling areas by keeping as clean and dry 149 
as possible and use appropriate disinfection.  For high sheep-traffic areas 150 
outside, such as gateways and around troughs, it may be appropriate to use 151 
lime or hard core. 152 
• Ensure good hygiene of equipment that contacts sheep feet by cleaning and 153 
disinfecting hoof knives and gloves/hands between sheep. 154 
• Biosecurity. Effective quarantine procedures are absolutely essential in 155 
preventing the incursion of types of Dichelobacter or treponemes that are 156 
novel to the flock. 157 
• Reduce the numbers of infected sheep in the flock by isolation, prompt 158 
treatment or culling of clinical cases. 159 
 160 
Protect 161 
Protection of the flock can be achieved through  162 
• Breeding lameness-resilient sheep and the culling of persistently lame sheep - 163 
two practices which require meticulous flock record-keeping.    164 
• Vaccination against footrot. This tool is often the most immediately useful to 165 
the practitioner wanting to make a clinical impact.  As with all vaccinations, 166 
the footrot vaccine is not a panacea, it cannot be relied upon in isolation.  167 
However, research [10], clinical experience and countless farmer testimonies 168 
suggest that footrot vaccination has a significant role to play in reducing a 169 
flock lameness issue to manageable proportions.  170 
The RUMA Targets aim to see an increase in the uptake of the Five Point Plan on 171 
sheep farmers and, as a quantifiable proxy of this, aim to see an annual 5% increase 172 
in the sales of footrot vaccine over the next five years [1]. 173 
Which antibiotic to use for clinical cases of footrot and CODD? 174 
Oxytetracycline is the most commonly used antibiotic for footrot and is generally 175 
effective for Dichielobacter. There are no licensed treatments for CODD, however, 176 
amoxycillin and tilmicosin have proven efficacy in vivo and in vitro for CODD 177 
treatment [8, 10].  The recent authorisation for both tulathromycin (Draxxin; Zoetis) 178 
and gamithromycin (Zactran; Merial Animal Health) specifically for the treatment of 179 
footrot in sheep has led to their widespread (but unauthorised) use against CODD 180 
with the particular advantage of their duration of action.  This is currently acceptable 181 
within the EMA definition of high priority critical important antibiotics though it 182 
would not be surprising if the goalposts were moved in the future. 183 
Inappropriate Antibiotic Use  184 
Two practices which have been widely used by some practitioners in recent years in 185 
the control of CODD and footrot, are whole-flock antibiotic treatments and foot 186 
bathing in antibiotic solutions.  Whole-flock antibiotic treatment has been shown not 187 
to be sufficiently effective to justify its high use of antibiotics [8] and cannot be 188 
advocated.  However whole-group treatment of infected sheep following careful 189 
segregation of lame sheep can be beneficial and should be considered. 190 
The lack of published evidence to support the benefit of antibiotic foot bathing, 191 
together with its use of high volumes of unauthorised products and insufficient 192 
guidance as to effective dose or appropriate disposal, means that this practice 193 
cannot be considered as an appropriate or responsible use of antibiotics. 194 
 195 
Enzootic Abortion  196 
Abortions and stillbirths cause significant losses to UK sheep flocks with 30% of total 197 
lamb losses attributed to the period between scanning and lambing (fig 4)  [11]. 198 
Enzootic Abortion of Ewes (EAE, caused by Chlamydia abortus) is the most 199 
commonly diagnosed cause in the UK (35% of all ovine abortion 2012-2018; GB 200 
Sheep Disease Surveillance).  Effective vaccines are available against EAE and should 201 
be used as the first line in protecting at risk flocks. Whole flock, prophylactic 202 
antibiotics are not considered necessary nor appropriate for control of EAE in sheep 203 
flocks  204 
Plan 205 
Replacement ewes are the primary source of infection in EAE naïve flocks. If it is 206 
necessary to buy in replacements an effective biosecurity plan is required. 207 
• Source replacements from EAE accredited free flocks 208 
• Alternatively, animals should be sourced from as few flocks as possible, from 209 
flocks with a known disease history and flock vaccination strategy should be 210 
designed and implemented.   211 
In addition, ewes from different sources should not be mixed for the first time whilst 212 
they are pregnant and purchased ewes should be kept separate from the home flock 213 
until after their first lambing.   214 
Diagnosis of the cause of abortion is essential for ongoing control and to this end, 215 
aborted material should be taken for laboratory diagnosis and aborted ewes clearly 216 
identified so that serology can be undertaken.  217 
Prevent 218 
An aborting ewe is the primary source of infection for Chlamydia abortus. Therefore 219 
to reduce the infection load for infectious aborting agents from any aborting ewe 220 
• Isolate ewe from the rest of the flock as soon as possible.   221 
• All aborted material should immediately be removed, destroyed or sent for 222 
laboratory investigation. 223 
• Clean, disinfect, remove or destroy contaminated bedding. 224 
• Ewe lambs intended to be kept within the breeding flock should not be 225 
fostered on to ewes that either aborted or produced dead lambs. 226 
• All human personnel should also be protected from aborting ewes and it is 227 
not advisable for pregnant women to be involved with either ewes or lambs 228 
around lambing time. 229 
Protect  230 
Vaccination strategies.  231 
• Vaccination against enzootic abortion, is much more effective when 232 
administered before exposure to disease so in high risk flocks it is advisable 233 
as a precautionary measure.   Flocks that are high risk for EAE to be 234 
introduced are those that buy in replacement ewes from flocks of unknown 235 
status.  Even closed naïve flocks with close neighbours of unknown status 236 
with adjacent lambing fields, could also be considered as at risk and 237 
precautionary vaccination would be advisable.   238 
• In the face of an outbreak of enzootic abortion, it is preferable to use an 239 
inactivated vaccine (eg Mydiavac; Benchmark) as soon as possible to reduce 240 
the spread of disease in the flock.  In the year immediately following 241 
abortion due to Chlamydia, it is expected that either a live or an inactivated 242 
vaccine should be given to the whole flock by at least three weeks before the 243 
ewes are put to the ram (unless they were vaccinated in the face of the 244 
outbreak).   245 
Inappropriate Antibiotic Use  246 
There are areas of the country where there is evidence that certain farmers are still 247 
using prophylactic treatment of all ewes as a routine in late pregnancy to control EAE 248 
abortion.  An unpublished questionnaire survey undertaken in 2015 suggested that 249 
this practice may be routine for 10% of sheep farmers [12].  250 
Antibiotic treatment of ewes in late pregnancy, generally using a long-acting 251 
oxytetracycline, may help to reduce the number of ewes that abort but it does not 252 
reduce the shedding of Chlamydia, nor reduce the incidence of infected ewes within 253 
a flock.  Neither is this a cost-effective approach when compared to vaccination over 254 
the medium to long term. It is not acceptable to use antibiotic to control abortion on 255 
an ongoing basis. 256 
If it is not possible to use a dead vaccine in the immediate face of a new outbreak, it 257 
is acceptable to treat the affected group of ewes with injectable long-acting 258 
oxytetracycline. It is also acceptable to use this antibiotic treatment for later lambing 259 
ewes within the flock, when they reach the period between day 90 and day 126 of 260 
that pregnancy or at the same stage for the affected group of ewes during their 261 
following pregnancy.  262 
It is not acceptable to use routine antibiotic treatment in the period of late 263 
pregnancy as a control measure for abortion in general - i.e. in any flock unless in the 264 
face of an outbreak or if there has been a confirmed laboratory diagnosis of 265 
Chlamydia in the immediately preceding year. 266 
 267 
Neonatal Lamb Bacterial Infections 268 
 269 
Lamb morbidity and mortality due to the bacterial, infectious syndromes of “Watery Mouth 270 
Disease” (fig 5) and “Joint ill” (fig 6) are common on UK sheep farms. Over the past 30 years, 271 
on many farms we have come to rely on prophylactic use of antibiotics to whole crops of 272 
neonatal lambs for their control (fig 7). In 2015 there were 10.5 million doses of oral 273 
antibiotics (Orojet: Zoetis and Spectam:Ceva; figure 4) sold in the UK (CEESA International 274 
Sales Survey) and farmers report that veterinary surgeons in some regions will also 275 
prescribe antibiotic tablets to sheep flocks for prophylactic use in neonatal lambs.  There are 276 
no antibiotic tablets licensed in food-producing animals so these antibiotic sales are not 277 
included in the UK Veterinary Antibiotic Resistance and Sales Surveillance Report (VARSS) 278 
reports.  As recently reminded in published letters, veterinary surgeons are in the privileged 279 
position of being allowed to prescribe medicines under the veterinary cascade, but the use 280 
of any unauthorised products must be fully justified and have clearly auditable clinical 281 
evidence [13]. 282 
It is clear therefore that routine whole lamb crop prophylactic use of antibiotics for the 283 
whole lamb crop for the whole lambing season, is no longer considered a sustainable nor 284 
acceptable solution in most cases. That said, as veterinary surgeons our first priority must 285 
always be to the welfare of animals under our care, and a change in disease control policy 286 
on a farm should never be implemented without farm specific risk assessment and 287 
management through the health planning process. This is particularly important at the high 288 
risk lambing period. 289 
 290 
 291 
“Watery Mouth” and joint ill 292 
  293 
Watery Mouth Disease (WMD) is an endotoxaemia of neonatal lambs (figure 5). The disease 294 
is characterised by dullness, depression, salivation from the mouth, with or without 295 
abdominal distention and is typically associated with E coli infection. Morbidity and 296 
mortality can be high in a flock and for many years disease control has strongly relied on 297 
prophylactic administration of oral antibiotics to the neonate. Non antibiotic control 298 
measures have centred around ensuring timely and adequate intakes of ewe colostrum to 299 
the new born lamb and establishing good ewe and environmental hygiene [14].  Treatment 300 
strategies include use of non-steroidal anti-endotoxic drugs, fluids and antibiotics. 301 
Evidence, suggests that Streptococcus dysgalactiae is the most common cause of joint ill (fig 302 
6) in lambs under four weeks old in British sheep flocks [15].  Erysipelothrix rhusiopathiae is 303 
another agent that can cause septic arthritis in sheep, though typically this is in older lambs 304 
or adults and not in lambs less than one month of age, with a diagnosis on positive serology 305 
of affected cases  Whilst in tick areas consideration should be given to Staphylococcus 306 
aureus associated with tick bites as the cause of infectious arthritis. Full consideration of the 307 
epidemiology and risk factors for these diseases is beyond the scope of this article, however 308 
there is an excellent recent review [16].  309 
In general terms, for all forms of septic arthritis, early detection and treatment is essential 310 
and it is always appropriate to undertake diagnosis to identify the causative pathogen and 311 
antibiotic sensitivity profile – by arthrocentesis of affected joint for culture and sensitivity 312 
and/or post-mortem examination of untreated animals (fig 8). Ideally, multiple animals 313 
should be sampled to improve the chance of a diagnostic result.  Clinical cases that are not 314 
treated promptly will respond poorly to antibiotic therapy.  Culture and sensitivity results 315 
will inform the choice of antibiotic for treatment but it should be noted that oxytetracycline 316 
is seldom effective [17].  It is appropriate that severely lame lambs, that show insufficient 317 
clinical improvement within five days of treatment, are euthanized.  Common control 318 
measures have involved whole lamb crop prophylactic administration of antibiotics.  319 
However, recent research and clinical experience has emphasised the role of high 320 
environmental, equipment, and personal hygiene standards at lambing time and ensuring 321 
adequate and timely colostrum intakes. 322 
 323 
A summary of the Plan, Protect, Prevent approach is shown in figure 9. 324 
Plan 325 
• Ewe nutrition. Appropriate nutritional management of pre- and post-lambing ewes is 326 
absolutely essential for ensuring lamb and ewe health. It ensures good lamb birth 327 
weight, lamb vigour, brown fat stores, ewe colostrum quality and quantity and 328 
influences ewe maternal behaviour. Therefore nutritional planning is necessary in any 329 
preventative health plan for neonatal lamb disease. This should include ewe body 330 
condition score as well as the quality, quantity, and accessibility to the diet. Readers are 331 
referred to the recent AHDB manual for an excellent guide to the topic [18].   332 
• Housing should be planned to meet recommended stocking rates, group sizes and 333 
provision of suitable mothering pens [19]. 334 
• Neonatal lambs should be protected from stress by provision of adequate shelter 335 
from inclement weather. 336 
• Husbandry tasks should be planned also to reduce stress. For example the need for 337 
tailing and castration should be scrutinised as well as the timing that they are 338 
undertaken (with recommendations of not before 24 hours old). 339 
• Ewe lameness kept well controlled. 340 
• Provision of sufficient competent staff to supervise the lambing period. 341 
 342 
 343 
Prevent  344 
To reduce the burden of pathogens the lambs are exposed to, ewe, equipment and 345 
environmental hygiene should be optimal. Their role in joint ill prevention, even in what 346 
appear to be farms with good standards of hygiene, has recently been highlighted. 347 
• Ewes should be dagged or sheared pre-lambing 348 
• When lambing assistance is required, clean gloves should be used for all ewes and 349 
hands and equipment regularly washed. 350 
• The lambing environment, for both indoor and outdoor systems, should be sheltered 351 
and as hygienic as possible with appropriate stocking densities and lie-back area. 352 
• Lambing pens should be dry, draft-free and cleanly bedded with appropriate 353 
cleansing and disinfection between occupants.   354 
• Navels should be appropriately and effectively treated as promptly as possible after 355 
birth. 356 
• Husbandry procedures such as stomach tubing, ear tagging, castration or tailing 357 
should be undertaken with close regard of hygiene.  All equipment should be 358 
suitable cleansed and disinfected between individual animals. 359 
 360 
 361 
 362 
Protect 363 
The recent campaign “Colostrum is Gold” is designed to emphasise to farmers the critical 364 
role of ensuring adequate and timely colostrum intakes for the neonatal lamb.  Current 365 
guidelines are 366 
• 50ml/Kg BW as soon as possible after birth with a total of 200ml/kg within the 367 
first 24 hours.  368 
• Where there is any doubt about effective passive transfer of colostral immunity, 369 
the situation should be monitored by testing blood samples from lambs under 5 370 
days old (e.g. Zinc Sulphate turbidty (ZST) test or total protein). 371 
• Vaccination of pregnant ewes against clostridial disease 372 
• Vaccination for joint ill is possible if Erysipelothrix rhusiopathiae is confirmed to 373 
be the cause of the joint ill and following due consideration of the risks and 374 
responsibilities associated with the prescription of an unauthorised product [20].  375 
 376 
Appropriate Antibiotic Use  377 
• Treatment of joint ill and WMD cases. First line treatments should be planned 378 
ahead with the farmer and reviewed in the health plan. Treatment should be 379 
prompt, full courses should be given, and ideally based on culture and sensitivity 380 
analysis.  381 
• Where there are farmers who are used to giving prophylactic antibiotic 382 
treatment to all lambs within a flock, it is suggested that vets should undertake 383 
risk assessment for different groups of lambs in the flock as shown in figure 10 384 
with a rough worked example shown in figure 11.  Good management and 385 
planning is the key to reducing the risk of disease and control measures should 386 
be discussed between the farmer and vet well ahead of lambing time, ideally at 387 
mid pregnancy, to give sufficient time to assess and implement new actions. 388 
• Antibiotic treatments should be targeted only towards highest risk individuals, 389 
following a proactive flock health plan. Figure 12 gives suggested criteria for 390 
categorising the risk associated with lamb, ewe and environmental factors. 391 
• Investigation of suspected treatment failure should be based on bacteriological 392 
culture and monitoring of the sensitivity of the pathogen to the antibiotic used 393 
on an individual farm.  There are significant levels of resistance in E coli isolates 394 
from sheep, with higher levels in neonatal lambs (figure 13;[21])  This clearly 395 
emphasises the urgent need for farms to employ non-antibiotic preventative 396 
strategies and for vets to prescribe according to current professional guidance  397 
[22]  398 
Inappropriate Use 399 
• Whole-flock injectable or oral antibiotic treatment of lambs in order to 400 
prevent “Watery Mouth Disease“ or “Joint-ill”  is very rarely appropriate as a 401 
routine management action.  402 
• Use of unlicensed medicines, unauthorised for use in food-producing animals, 403 
unless justified under the “cascade”. 404 
• Use of the high-priority critically important antibiotics (fluoroquinolones, 405 
systemic 3rd and 4th generation cephalosporins and colistin, as designated by 406 
the European Medicines Agency and the VMD) Box 2. These are already used 407 
at very low levels within the UK sheep industry [1].  Practitioners are urged to 408 
only use them in sheep under exceptional circumstances, where culture and 409 
sensitivity clearly indicate that there is no alternative appropriate antibiotic 410 
and follow appropriate licensing regulations. 411 
 412 
.  413 
 414 
 415 
Implementation 416 
Reduction, replacement and refinement of antibiotic use in sheep flocks should be 417 
implemented by a whole veterinary practice, planned approached [23], and not left to 418 
individual vets in the practice to address when the client appears at reception with a 419 
“shopping list”! Otherwise the practice risks poor animal welfare and damage to 420 
relationships with clients. It will require closer engagement with sheep farmer clients in 421 
preventative medicine through activities such as flock health planning, regular farmer 422 
meetings and vet/farmer clubs [24]. Practitioners should be encouraged to collate individual 423 
flock usage for auditing purposes as well as to satisfy recently updated Red Tractor Farm 424 
Assurance guidelines.  Through improvement in preventative medicine uptake in sheep 425 
flocks there is considerable potential to improve sheep flock health, welfare and economic 426 
performance whilst addressing the global public and animal health challenge of emergent 427 
antibiotic resistance.  428 
  429 
 430 
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Figures 495 
Figure 1 Proportion of antibiotic prescribed to 24 sheep-only farms of over 100 breeding ewes, 496 
between August 2015 and July 2016.  ‘Others’ made up of lincomycin 4.7%, fluoroquinolones 0.5% 497 
and florfenicol 0.5%, with the remaining 0.9% consisting of cephalosporins, sulphonamides, 498 
trimethoprim and thiamphenicol  (Davies et al 2017)  499 
 500 
Figure 2 Infectious Foot Disease Lesions in Sheep  501 
A Interdigital dermatitis (scald) 502 
B Foot rot 503 
C Contagious Ovine Digital Dermatitis (CODD 504 
 505 
Figure 3 The Five Point Plan (Clements and Stoye 2014) 506 
 507 
Figure 4 Indication of the proportion of lambs lost at different stages of development 508 
 509 
Figure 5: Lamb with Watery Mouth Disease 510 
 511 
Figure 6: Lamb with Joint Ill 512 
 513 
Figure 7 Administering oral antibiotic to a neonatal lamb  514 
 515 
Figure 8 Post mortem examination of lamb with joint ill (photo Phillipa Page)  516 
 517 
Figure 9 An infographic describing the Plan, Prevent, Protect strategy with respect to controlling 518 
bacterial neonatal lamb diseases  519 
 520 
Figure 10 Suggested flow chart of the steps to undertake risk assessment on groups of lambs within 521 
the flock with a sketched-out example (figure 11) 522 
 523 
Figure 11 Example flock with rough detail of application of risk assessment  524 
 525 
Figure 12 Suggested scoring system for assigning risk to lambs based on factors relating to the lamb, 526 
the ewe and the environment.  Clearly it is not expected that this will be undertaken for every lamb 527 
but it can be used to indicated different risk groups (as identified in figure 10) 528 
 529 
Figure 13 Total number and percentage of resistant isolates of Escherichia coli from sheep (by age 530 
category) in 2016 taken from VARSS report (VMD 2017) 531 
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